Stay updated on NIMBLe Study: Clinical Trial_hyperMutated Cancers
Sign up to get notified when there's something new on the NIMBLe Study: Clinical Trial_hyperMutated Cancers page.

Latest updates to the NIMBLe Study: Clinical Trial_hyperMutated Cancers page
- Check4 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check11 days agoChange DetectedA site-wide notice says NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check18 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check25 days agoChange DetectedThe site footer’s revision indicator changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now shows a 403 Forbidden error (with basic navigation like Home and a revision banner), and the previously listed trial content appears to be removed, indicating the study record is no longer accessible.SummaryDifference19%

- Check67 days agoChange DetectedThe page’s revision label updated from Revision: v3.6.5 to Revision: v3.6.6, indicating a minor system update. No substantive study content appears to be affected.SummaryDifference0.1%

Stay in the know with updates to NIMBLe Study: Clinical Trial_hyperMutated Cancers
Enter your email address, and we'll notify you when there's something new on the NIMBLe Study: Clinical Trial_hyperMutated Cancers page.